Press Release: DC Has Highest Ovarian Cancer Rate in US: Local Survivor Raises Awareness and Funds

Washington, DC has the highest ovarian cancer rate in the nation. As Survivors Committee Chair and Spokeswoman for the National Race to End Women’s Cancer, Jennie learned first hand the importance of seeking care first from a gynecologic oncologist if you suspect or have been diagnosed with a gynecologic cancer.

Following a series of appointments, tests, treatments, complications, infections, fatigue, roiling emotions, forgetfulness and pain, two life-altering surgeries and six rounds of chemotherapy later, Jennie has been cancer free for almost two years.

“I learned about being a survivor from my mom, who was diagnosed with cervical cancer — another reproductive cancer — when I was seven,” Jennie says. “28 years later, she continues to inspire me every day.”

Jennie, a senior marketing manager for Deloitte Services, also knows how to motivate individuals and organizations — and uses those skills to raise awareness and crucial financial support for research on women’s cancers.

“Twenty years ago a group of dedicated women got together and waged a battle to save lives,” Jennie points out. “That movement resulted in an explosion of awareness and research funding for breast cancer and today, 34% less women die of that disease. It’s time to wage a similar battle against gynecologic cancers.”

Jennie urges others to help save women’s lives by registering for the National Race to End Women’s Cancer on November 6th in Washington, DC. Those who aren’t runners or can’t make it to Washington can still participate and support the cause by joining a “virtual team.”

For more information and to register,


Visit the Sisterhood of Survivorship page to read “Dena’s Story” — by a vulvar cancer survivor who has shared her story and wise words, and channeled her energy into her National Race to End Women’s Cancer team.


Vaccine efficacy against vulvar infection with HPV 16/18 was comparable to the efficacy found against cervical infection 4 years after vaccination, according to researchers with the National Cancer Institute.


The Foundation has published its 2014-2015 Research Grants and Awards Booklet with Applications. Please consider applying to become part of an elite group of physician-scientists committed to the well-being of women at risk for/affected by gyn malignancies.


The next Ovarian Cancer Survivors Course will be Saturday, July 26, 2014 in Boston. For more information on courses, click here.